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Abstract: The ecological community of microorganisms in/on humans, termed the microbiome,
is vital for sustaining homeostasis. While culture-independent techniques have revealed the role
of the gut microbiome in human health and disease, the role of the cutaneous microbiome in
wound healing is less defined. Skin commensals are essential in the maintenance of the epithelial
barrier function, regulation of the host immune system, and protection from invading pathogenic
microorganisms. In this review, we summarize the literature derived from pre-clinical and clinical
studies on how changes in the microbiome of various acute and chronic skin wounds impact wound
healing tissue regeneration. Furthermore, we review the mechanistic insights garnered from model
wound healing systems. Finally, in the face of growing concern about antibiotic-resistance, we will
discuss alternative strategies for the treatment of infected wounds to improve wound healing and
outcomes. Taken together, it has become apparent that commensals, symbionts, and pathogens on
human skin have an intimate role in the inflammatory response that highlights several potential
strategies to treat infected, non-healing wounds. Despite these promising results, there are some
contradictory and controversial findings from existing studies and more research is needed to define
the role of the human skin microbiome in acute and chronic wound healing.
Keywords: skin; wound healing; microbiome; infection; antibiotic resistance; commensals
1. Introduction
The human microbiome is a vital component in both the maintenance of human health and
the establishment of human disease. The number of all microbial cells that inhabit the human
body outnumbers host cells by a factor of 10, while the number of genes is eclipsed by a factor
of 100. Next generation sequencing methods have allowed us to link alterations in the gastrointestinal
microbiome to the pathogenesis of autoimmune, metabolic, and atopic diseases [1–4]. Despite the fact
that similar proportions of host to microbial cells exist on the cutaneous microbiome [5], the impact of
the cutaneous microbiome on acute and chronic wound healing is less defined.
Both in-vivo and in-vitro studies of the cutaneous microbiome have supported a general consensus
that the microbial composition of skin wounds impacts wound healing. However, the conclusions
drawn from these studies have been conflicting. Canesso et al. demonstrated that in the absence of
commensal skin microbiota, Swiss mice demonstrated accelerated wound closure and epithelization
with a significantly altered wound leukocyte profile [6]. In addition, Germ-Free mice demonstrated
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increased levels of anti-inflammatory cytokines, upregulation of vascular endothelial growth factor
(VEGF), and decreased scar formation [6]. When the skin microbiota were restored, their wound healing
profiles were similar to that of conventional mice, suggesting that commensal bacteria may impede
wound healing. In contrast, oral Vancomycin-treated rodents were found to have decreased bacterial
density of skin wounds and slower wound healing rates, potentially due to the downregulation of
proteins interleukin (IL)-17 and regenerating islet derived protein-III gamma (RegIIIy) which are
essential for keratinocyte differentiation and proliferation [7].
These conflicting studies suggest that the impact of the microbiome on wound healing is
multifaceted, and a balance between types of organisms (e.g., viruses vs bacteria, Gram Negative vs.
Gram Positive, etc.) is needed to promote skin health and regeneration. Simple reductions in bacterial
burden achieved through anti-microbial treatments may reduce beneficial bacteria, and alternative
strategies should be considered, especially considering the concerns over antibiotic resistance. In this
review, we analyze the current literature regarding the impact of the skin microbiome on wound
healing. We will start by discussing the constituents of the normal human microbiome and how it is
altered in acute and chronic wounds. We will then consider preclinical studies that include both animal
and in vitro model systems to identify molecular targets that may be leveraged to promote wound
healing and tissue regeneration. Finally, we discuss the question: Can the microbiome be modulated
or changed to promote optimal wound healing and improve patient outcomes?
2. Defining the Healthy Skin Microbiome
2.1. Bacteria
An individual’s skin microbiota is established intra-partum, with maternal delivery playing a vital
role in microbial composition [8]. Site specific colonization, demonstrated by microbial communities
residing in distinct epidermal topographical niches, is a key feature of the human skin microbiome [9,10].
It is now apparent that at least 19 bacterial phyla and over 1000 bacterial species have been identified
within the most superficial level of skin [9,11]. The most commonly represented epidermal bacterial
phyla include Actinobacteria (52%), Firmicutes (24%), Proteobacteria (17%), and Bacteroidetes (7%),
whereas the most commonly represented genera (phyla) include Corynebacteria (Actinobacteria),
Propionibacteria (Actinobacteria) and Staphylococci (Firmicutes) [9,11]. Microbial composition varies
across skin sites, both due to moisture content and anatomical location. For example, sites containing
many sebaceous glands (e.g., glabella, alar crease, external auditory canal, retroauricular crease,
occiput, manubrium, and back) often contain the greatest bacterial load [12] and are mainly
dominated by Propionibacterium and Staphylococci spp., whereas moist sites are dominated by
Corynebacteria and Staphylococci spp. [9]. Dry sites (e.g., volar forearm, hypothenar palm and buttock),
despite demonstrating the greatest microbial diversity and variability overall, contain a greater
abundance of β-proteobacteria, Flavobacteriales, and other Gram Negative organisms [9,13]. In addition
to epidermal colonization, recent literature has revealed that the healthy skin microbiome extends
into the sub epidermal compartments with higher proportions of Proteobacteria (Burkholderiales and
Pseudomonadales species) and Actinobacteria and a lower abundance of Firmicutes [14].
2.2. Fungi
Less commonly defined is the fungal component of the microbiome (i.e., mycobiome).
Interestingly, some studies have shown that (in contrast to bacteria) fungal species often differ
by anatomical location (head, torso, arm, leg, and feet) independently of moisture or sebaceous
content [15]. While cultivation methods in earlier studies have shown that the Malassezia genus is
the major component of the skin fungal community, sequencing of 18S rDNA in healthy patients
has confirmed that Malassezia organisms (which includes some known pathogens) dominate the
mycobiome on most skin sites [16,17], with colonization of the feet being an exception. The increased
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display of fungal diversity and lower stability of fungal organisms in this area might explain why
diseases of the heel, toe web, and toenail are common sites of recurrent fungal infections.
2.3. Viruses
Methods to characterize the human skin microbiome have mainly focused on targeting bacterial
and fungal signatures through ribosomal DNA-based amplification. Given the lack of such sequences
in virus and bacteriophage genomes along with the low relative abundance of viruses in the skin,
amplicon detection of the viral/phage microbiome via standard methods remains challenging [18–20].
In addition, the occurrence of “Viral Dark Matter” defined as metagenomic sequences originating
from viral genomes that have not been aligned with their host microbes are a major obstacle in
comprehensively defining the skin virome [21]. However, most recently, high throughput metagenomic
sequencing and polymerase chain reaction (PCR) quantification have identified the Human Papilloma
Virus (Papillomaviridae (HPV)) as one of the most common species within the healthy skin virome [22–24].
In addition, the Human Polyomavirus and Circoviruses are main components of the skin virome
identified through the use of whole metagenomic analysis [25]. Moreover, bacteriophages are also
major components of the skin virome. Staphylococcus phages were found to contain hypervariable
loci in the virome of healthy human volunteers, whereas Propionibacterium phages were found to be
minimally divergent. The abundance of these bacteria infecting microbes has allowed us to identify
them as potential targets in wound healing; recent potential therapeutic targets for adult acne have
included phage-based therapies [26]. Likewise, more studies are needed to elucidate the impact of
vaccinations combating viral pathogens on skin viral commensals. For example, a recent case report
found that widespread HPV-2 positive warts completely regressed following administration of HPV
vaccination in a young boy [27].
2.4. Other Factors Defining the Skin Microbiome
While much of the research characterizing the healthy human skin microbiome focuses on
anatomical locations and water/oil content, it has been shown that genetics and environmental
factors such as climate also help define the normal flora [28]. For example, skin commensals of
the forearms of Venezuelans (dominated by Staphylococcus and Proteobacteria) differed considerably
from that of Americans (dominated by Propionibacterium) [29]. Moreover, in addition to age and
gender, the microbiome can predict whether inhabitants live in an urban or rural area within the same
metropolitan area [30]. Similarly, Hospodsky et al. demonstrated that the hands of Tanzanian women
had a greater abundance of soil associated microbes such as Rhodobacteraceae and Nocardioidaceae
compared to women in the United States [31]. Lastly, Leung et al. introduced the concept of the
pan-microbiome to suggest that the microbial members of the skin microbiome varied across countries,
with specific differences in Chinese individuals when compared to other racial groups (e.g., Americans,
Tanzanians) [32]. Because differences in skin commensals may affect progress in wound healing and
subsequent treatment, the above ethnic and environment related differences underscore the need to
expand current knowledge to more diverse geographic and cultural populations.
3. The Cutaneous Microbiome: Aberrations in Human Wounds
Wound healing is a multi-layered process consisting of sequential yet overlapping phases that
begin as an inflammatory response to the physical disruption of tissue [33]. Indeed, because wound
healing is intimately tied in with inflammation and immune cells [34], much of the molecular
information on the effects of commensal and pathogenic bacteria are tied to inflammatory signaling.
However, comparatively speaking, there are many more studies that examine wound healing
histologically than there are molecular analyses. While the wound healing process has been
characterized extensively, the burgeoning field of microbiome analysis is just beginning to be
understood. As summarized below, many studies have concentrated on the relative amounts of
different bacterial flora, such as identifying the major phyla, genus, and so on, located within different
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types of wounds. However, determination of overall bacterial diversity that leads to skin dysbiosis
may be more revealing [35]. Using the gut as an example, both alpha-diversity (microbial variety
within a given population) and beta-diversity (microbial variety between populations) have been
differentially affected by factors such as diet [36] and may have implications for chronic disease
development [37]. For the skin, treatment of atopic dermatitis with emollients was shown to improve
symptoms, increase microbial diversity, and decrease Staphylococcus abundance [38]. In terms of
wounds, the study of diversity has largely been limited to diversity of biofilms that form in chronic
wounds [39], which will be discussed first. However, it should be noted that because much of the focus
has been on bacterial burden and specific organism changes, there remains a considerable amount to
discover regarding the role of altered diversity measures in wound healing.
3.1. Chronic Wounds
Chronic, hard-to-heal wounds such as diabetic foot ulcers (DFU), decubitus ulcers (DU),
venous leg ulcers (VLU), and post-surgical wounds generate a major burden not only for the patient
and their provider, but also for the healthcare system; it is estimated that the treatment of these
chronic wounds accounts for up to 25 billion US dollars annually [40]. Polymicrobial biofilms,
which foster pathogenic microbial growth and disrupt the coordinated events of wound healing,
are highly abundant in chronic wounds and play a vital role in the pathogenesis of impaired cutaneous
healing [41,42]. A clinical study examining 50 chronic wound specimens from adult patients revealed
a greater prevalence in biofilm production in 60% of chronic wounds compared to only 6% of acute
wounds [41]. In addition, Wolcott et al. identified Pseudomonas as not only the most dominate genera
in chronic wound biofilms, but also the most common microbe seen in biofilms formed from a single
species [42]. Biofilms form as a result of microbial aggregation on a surface, encased in an exo-polymeric
substance consisting of polysaccharides, lipids, and protein [43]. Through this matrix-type substance,
microbes are able to alter their proliferative rate, metabolic activities [44], and develop a phenomenon
known as quorum sensing, which is the ability for microbes to communicate changes in response
to population density through the production of organic signaling molecules [45]. Biofilms provide
continuous stimulation to the innate immune system, which ultimately delays progression to the
proliferative phase of wound healing.
The microbial composition of human skin is not static, and the presence and abundance of
microbes in skin wounds depend on wound type. The three main phyla identified in pressure ulcers
are similar to that of healthy commensals (e.g., Firmicutes, Proteobacteria, and Actinobacteria) [46]. In a
large clinical observation study of 2963 patients with wound samples from 910 DFUs, 916 VLUs,
767 DUs, and 370 non-healing surgical wounds, Wolcott et al. [42] demonstrated that Staphylococcus
(Gram Positive) was the most frequently encountered genera. S. aureus and S. epidermidis were
identified as the most abundant species in chronic wounds. Moreover, although bacterial diversity
was independent of chronic wound type, S. epidermidis was found to be more prevalent in DFUs,
and Pseudomonas aeruginosa (Gram Negative) exhibited a higher relative abundance overall in chronic
wounds demonstrating biofilm formation. This study confirmed culture and electrophoresis techniques
previously used by James et al. that identified Gram Positive cocci as the most abundant bacteria.
However, in the case of biofilm formation, Gram Negative rods were the most abundant. Once again,
both Staphylococcus and Pseudomonas were common in all chronic wound types [41]. Even though
chronic wounds are naturally exposed to high levels of oxygenation, anaerobic bacteria have a stern
presence in chronic wounds more so than acute wounds. Anaerobes such as Fingelodia, Prevotella,
Peptonipihlus, Peptostreptococcs, and Anaerococcus have been identified as consistent microbial members
of the chronic wound microbiome.
In terms of alpha-diversity, DFUs have been shown to be significantly less diverse then control
skin both in species richness and evenness as measured by Chao and Shannon indices [47]. In addition,
the beta diversity of microbial communities of control skin are significantly different than that
of DFUs, as confirmed by permutational multivariate analysis of variance (PERMANOVA) [47].
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Although Dowd et al. revealed Corynebacterium to be the most prevalent genera in 40 chronic
DFUs, Gardiner et al. found Staphylococcus to be the most abundant genera in DFUs compared
to controls [47,48]. Furthermore, the temporal stability of diversity measures is associated with
healing outcomes. Although studies have shown that disease states are associated with less stability
in the gut [49], destabilization may prove to be advantageous if the existing microbiota do not
promote cutaneous wound healing. For example, Loesche et al. showed that DFUs were comprised
of 4 community types, and the length of healing was associated with more transitions between these
community types [50]. Moreover, they found that systemic antibiotics destabilized these pathogenic
wound microbiomes resulting in faster wound healing, suggesting a role for antibiotics in targeting
aberrant microbiome communities.
Although most studies focus on the presence of bacteria in chronic wounds, others have
drawn attention to fungal communities. Fungal communities are common pathogens of various
pedal infections and have now been identified as major players in the pathogenesis of non-healing
wounds. Kalan et al. [51] identified a high prevalence of fungal communities in 100 non-healing
DFUs. The most abundant fungal communities identified were Asomycota (Cladosporidium herbarum
and Candida albicans) and Basidomycota (Trichosporon and Rodhosporidum). The researchers also
demonstrated that administration of antibiotics, as well as the occurrence of clinical complications,
were associated with increased fungal diversity, and classified pathogens were elevated in necrotic
wounds. Clearly, more work needs to be done to fully grasp the role of fungi, and the interaction with
other microbes in the context of wound healing [52]. Further understanding of these aspects of the
microbiome may lead to better treatments for promoting wound healing.
3.2. Acute Wounds
While the bulk of clinical research on the role of various microbiomes on wound healing has
focused on chronic wounds, acute wounds (e.g., burns, blunt traumas, and penetrating traumas)
are also of interest. One clinical study demonstrated that cutaneous burns significantly altered
microbial skin profiles, and adjacent skin of burn sites exhibited a more similar skin microbiome to
that of the burn margin as opposed to that unburned controls [53]. Burn wounds in these patients
revealed an increased abundance of thermophile microbes such as Aeribacillus, Caldalkalibacilus,
and Nesterenkonia and decreased abundance of Corynebacterium, both in the wound center and the skin
margin. Indeed, topical antibiotics have largely aided burn wound outcomes by effectively treating
Psuedomonas colonization. However, changes in the cutaneous microbiome were also associated
with post burn complications, with Corynebacterium demonstrating a positive correlation with burn
wound infection, and Staphylococcus and Propionibacterium demonstrating a negative correlation with
post burn infection [53]. Interestingly, Liu et al. also exhibited that skin dysbiosis is an expected
consequence of burn injury that persists after healing [54]. In burn scars, community richness (an alpha
diversity measure that represents the number of taxa in a population) was decreased even though
these sites had an increase in bacterial diversity overall with an increased abundance of Firmicutes and
Staphylococcus spp. compared to control skin [54]. However, all of these burn wounds demonstrated
successful wound healing, and it was not examined if these changes in microbial composition adversely
impacted wound healing rates.
Similar to burn injury, the wounds created as a result of blunt or penetrating traumas also
exhibit changes in skin microbial composition and significant differences in beta diversity compared
to controls [55,56]. The microbial composition of open fracture wounds is even associated with
mechanism of injury [55]. The most dominant microbes in open fracture wounds and adjacent skin include
Staphylococcus, Corynebacterium, Streptococcus, Acinetobacter, Anaerococcus, Finegoldia, and Pseudomonas.
In this prospective observational study done by Bartow-McKenny et al., Pseudomonas was found to be the
dominant species at the wound center on initial presentation to the emergency department (ED). Over time,
the researchers found that the abundance of Staphylococcus greatly increased, and the abundance of
Pseudomonas significantly decreased in the wound center. While the changes seen clinically provide
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information as to which bacteria may hold valuable diagnostic information, the section below examines
molecular information from models that may be leveraged to modulate the microbiome and ensuing
inflammation to aid in wound healing.
4. The Microbiome, Wound Healing and Inflammation: Mechanistic Insight from Model Systems
Mechanistic insight into the relationship of the altered microbiome and cutaneous inflammation
has been aided by the use of preclinical studies, including animal models and in vitro systems.
Although the ideal cutaneous wound model has not yet been established, all of these model systems
may provide valuable mechanistic insight and act as screening tools for modulation of the human
skin microbiome. In general, all of the models described have merit for examining different aspects of
wound healing, and advantages of feasibility and throughput (e.g., in vitro models) may be initially
used over more translatable in vivo models.
In vitro studies evaluating the impact of biofilms on chronic wound healing have included both
epidermal and dermal investigations. Kirker et al. analyzed S. aureus-produced biofilms in a human
keratinocyte wound model and found that the presence of biofilms resulted in significantly reduced
scratch closure [57]. The Leiden epidermal model has also been used to study the impact of biofilms
by creating an artificial stratified epithelium from human keratinocytes that demonstrates normal
epidermal differentiation. Using this model, de Breji et al. demonstrated the ability for Acinetobacter spp.
such as A. baumanni and A. junii to colonize and form biofilms on the most superficial layer of the
epidermis (stratum corneum), which increased levels of IL-8 (a potent neutrophil chemoattractant) [58].
However, these organisms were not able to penetrate into the lower layers of the epidermis [58].
This same result was found with S. aureus as this microbe did not penetrate into the lower epidermal
structures [59]. In addition, the dermis of the skin contains a wide number of cells essential for wound
healing [60]. For example, biofilms have a detrimental effect on human dermal fibroblasts migration
and ultimately result in cellular apoptosis [61]. Moreover, when compared to conditioned media of
planktonic bacteria, S. aureus biofilm conditioned media increased the release of tumor necrosis factor
α (TNF-α) and decreased the release of interleukin (IL)-6, matrix metalloproteinase (MMP-3) and
VEGF from human dermal fibroblasts.
Rodents are often used for microbiome and wound healing research, however recent studies have
brought into question the relationship between rodent and human inflammation [62,63]. In terms
of wound healing, mice and rats have a thinner epidermis and dermis compared to humans,
which primarily heals by contraction and not re-epithelization. However, many studies are able to
overcome this difference with mechanical forces or other mechanisms [64]. Alternatively, large animals
such as swine have also been used, as pigs have been regarded as the closest surrogate to human skin
for similarities in structure and healing [65,66]. Recently, the porcine cutaneous microbiome has been
shown to affect in vitro wound healing of human keratinocytes [67], and to be closer to humans on a
relative scale [68]. However, dysbiosis and signaling pathways in, for example, atopic dermatitis have
been shown to closely align with what is seen in humans [69]. Moreover, swine also have disadvantages
when compared to rodents, including costs, handling, and the lack of genetic manipulability [65].
In short, the model chosen should be decided by the question being asked, as rodent models may
adequately address, for example, clearance from infection at a lower cost than large animals.
To that end, murine wound models have reinforced our understanding that S. aureus and
S. epidermidis biofilms delay wound re-epithelization in uninfected wounds, and this process has been
shown to be influenced by quorum sensing. For example, Schierle et al. [70] demonstrated that when
exposed to quorum sensing inhibitors (RNAIII inhibiting peptide), the cutaneous integrity of these
murine wounds was restored, abolishing biofilm formation and obliterating bacterial bioburden [70].
Quorum sensing inhibitors represent a broad range of enzymes and compounds that are produced
both naturally and synthetically [71]. For chronic wounds, agents that disrupt biofilm formation may
be an attractive adjuvant to antibiotics to combat the development of antibiotic resistance.
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The use of models to explore the effects of acute burn injury have also been studied.
Local burn injury has been known to increase epithelial permeability in even unburned skin,
exacerbating trans-epidermal water loss [72,73]. This raises the possibility of colonization/infection
of adjacent “normal” skin, resulting in poorer healing outcomes. Plictha et al. demonstrated in both
burned skin and distant unburned skin in C57 mice an increased abundance of anti-microbial peptides
(AMPs) and proteases, and a decreased abundance of kallikrein peptidases (an expected response of
skin inflammation) [72]. This effect elicits a decreased ability of the skin to inhibit the bacterial growth
of common skin pathogens such as S. aureus and P. aeruginosa.
Effects of Bacterial Colonization on Skin Inflammation and Cutaneous Homeostasis
Skin commensals influence a variety of cell signaling and homeostatic processes including
keratinocyte proliferation, epithelial differentiation, and epidermal blood vessel growth. While elevations
of microbial bioburden often result in infection, high diversity of skin commensals, as seen in healthy
microbial colonization, are also involved in both the benign induction of the immune system and
the attenuation of the immune response. For example, skin CD8+ T cells specifically elicited by
S. epidermidis promote rapid keratinocyte progression via upregulation of toll-like receptors (TLR) and
downstream modulation of TNF-α [74,75]. In addition, S. epidermidis’ production of lipoteichoic acid
decreases cutaneous inflammation via TLR2 signaling [76]. The ability of S. epidermidis to modulate
the innate immune response in non-infectious skin wounds coincides with its ability to accelerate
wound healing in various skin models, and highlights the ability for bacterial products to reduce
cutaneous inflammation.
Similarly, both S. epidermidis and the typically low-abundant S. aureus [77], induce expression of
AMPs in human keratinocytes, ultimately benefiting skin by providing host protection from invasion
of other pathogenic microorganisms [78,79]. An example of these AMPs is small cationic beta-defensin
molecules (hBD) which are expressed in all human epithelial cells and play a role in epithelial
differentiation [80]. Indeed, differential expression of these AMPs may confer the ability to amplify the
innate immune response to commensal bacteria [79]. This appears to be in part, completed through
known mechanistic pathways such as Nuclear Factor Kappa Beta (NF-κβ), Protein Kinase B (AKT),
and TLRs. Although hBD-1 is continually expressed in human epithelial tissue, hBD-2 and hBD-3 are
only expressed in skin tissue when stimulated by both pathogenic and commensal microbes including
S. epidermidis, S. aureus, and Group A streptococcus spp. (GAS) [80]. The ability for commensals to
facilitate production of these, exclusive yet beneficial, AMPs supports the idea that skin microbes
play a vital role in epithelial differentiation and the maintenance of skin-barrier function; a role that
cannot be fulfilled in their absence. The induced expression of these AMPs in the face of pathogens
also renders these attractive targets for treatments to accelerate wound healing.
Although S. aureus is a normal commensal of human skin flora (albeit rare), overabundance of
this microbe is associated with high rates of skin infection especially with production of superantigens
(SAg) that have varying effects at the local and systemic levels. While exceptionally deleterious
in high systemic concentrations, in small amounts, SAg production by S. aureus decreases local
downstream production of interleukins like IL-17 and subsequent neutrophilic chemotactic factors in
cutaneous tissue, resulting in decreased purulence of skin wounds and decreased skin inflammation
compared to non-SAg producing strains [81,82]. The relatively low abundance of SAg production in
these skin wounds might explain why the occurrence of the systemic cytokine storm seen in septic
patients does not immediately develop in patients demonstrating S. aureus colonization. In addition,
Secor et al. demonstrated that S. aureus biofilms resulted in significantly elevated keratinocyte
cytokines, such as IL-1B, IL-6, chemokine ligand (CXCL)-8, CXCL-1, and TNF-α, demonstrating
the potentially destructive effect these microbial products have on cutaneous inflammation [83].
The impact of Pseudomonas colonization on host epithelial tissue, once again highlights the diverse
responses in integumentary cell signaling initiated by differing microbe levels. On initial contact with
the skin, Pseudomonas localizes to the epithelial barrier of its host and at low levels this microbe not only
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accelerates epithelization, but also increases the rate of blood vessel growth in acute wounds through
keratinocyte growth factor-1 and alteration of previously mentioned cytokines [84]. Similarly, as seen in
a Schmidtea mediterranea wound model, a planaria organism known for its tissue regeneration abilities,
Pseudomonas stimulates the TAK1/MKK/p38 signaling pathway, ultimately repressing cell apoptosis
and improving wound healing outcomes in the absence of infection [85]. However, in the presence of
infection, stimulation of TAK1/MKK/p38 by Pseudomonas spp. induced cell apoptosis and ultimately
comprised tissue homeostasis, resulting in decreased frequency of neoblast cells and inhibition of
tissue regeneration of amputated planaria fragments [85].
The varying effects of skin microbiota on cell signaling pathways suggest that small amounts
of these potentially pathogenic microbes may in some cases aid rather than harm host cutaneous
tissue regeneration. However, as mentioned earlier, in the absence of skin microbiota in rodents,
wound healing was accelerated due to decreased abundance of bioactive markers secreted by recruited
neutrophils [86]. This finding supports the idea that the process of inflammatory stimulation
via bacterial colonization, although beneficial in many situations, may also adversely impact
healing outcomes due to the increased abundance of proteases, reactive oxygen species, and other
bioactive substances that delay wound healing. Another study supporting this theory found that
nucleotide-binding oligomerization domain-containing protein 2 (NOD2), a pattern recognition
receptor that recognizes bacterial peptidoglycans and consequently stimulates a host immune response,
was found to be upregulated in non-healing murine cutaneous wounds [87]. At this point, it appears
that various skin microbiota have both advantageous and detrimental effects on host cutaneous tissue
in both uninjured and injured skin, which may dictate whether these microbes take on the role of skin
commensal or skin pathogen. Taken together, preclinical models have identified a large number of
potential molecular targets, summarized in Table 1.
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Table 1. Skin commensals have varying effects on host cutaneous tissue and are associated with a variety of cell signaling pathways.
Bacteria Positive Effects Negative Effects Associated Signaling Pathways
Staphylococcus epidermidis
Stimulates keratinocyte production of host AMPs
(hBD3, RNase7) [22,74,75,88]
Induces CD8+ T and IL-17A+ T cells [79]
Enhances innate barrier immunity and limits pathogen
invasion in absence of inflammation [6,74,80,89]
Occasionally pathogenic
Implicated in production of biofilms [79,90–93]
NF-κB [74,76,89]
TRAF1 [7]
TLR2/CD36/CD14-p38, MAPK [7]
EGFR
TRAP [70]
Staphylococcus aureus
At a local level, super antigen production results in less
skin inflammation and purulence due to decreased
production of exotoxins and neutrophilic chemotactic
factors [81]
Amplifies innate immune response of skin via production
of AMPs (hBD-3, hBD2, LL-37, RNAse7) [78,79]
Usually pathogenic
Implicated in production of biofilms and delayed wound
healing in chronic wounds [91,92] Super antigen
production elicits robust activation of immune system [81]
TRAP [70,94]
phosphatidylinositol 3-kinase/AKT
NF/kB
ERK
TLR-2 [9]
Group A streptococcus (GAS)
Stimulates production of AMPs, promote epithelial
differentiation [95]
Activates plasminogen which promotes Keratinocyte
chemotaxis and potential re-epithelization of wounds [95]
Usually pathogenic
Express proteases which prevent neutrophil
recruitment [79,96,97]
Produces hyaluronidase which allows bacteria migration
through host Extracellular matrix [7]
Common cause of superficial and deep skin infections i.e.,
impetigo, erysipelas, cellulitis [6]
NF-κB/p65 [80]
Pseudomonas aeruginosa
Accelerates epithelialization and neovascularization in
acute wounds
Suppresses staphylococcal pathogens in polymicrobial
wounds [84]
Usually pathogenic
Implicated in production of biofilms and delayed wound
healing in chronic wounds [90–93]
Nod2 [87]
TAK1/MKK/p38 [85]
Corynebacterium jeikeium
Manganese acquisition and production of superoxide
dismutase result in host epidermal protection from free
radical oxygen species (ROS) [5]
Occasionally pathogenic
Common cause of nosocomial skin infections [95] N/A
Propionibacteria
Production of bacteriocins protect sebaceous ducts from
other pathogenic inhabitants [77]
induces expression of TLR2 and TLR4 in keratinocytes71
Occasionally pathogenic
Overabundance associated with development of Acne [5] N/A
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5. Modulating the Microbiome: Clinical Implications for Wound Healing and
Tissue Regeneration
With rising concerns regarding antibiotic over-prescription and the development of pharmacologic
resistance, finding alternative ways to modulate the microbiome in hopes of improving wound healing
is of the utmost importance. Figure 1 illustrates some of the molecular targets identified, as well as
other phenomenon that may be leveraged for accelerating wound healing. Clinical applications that
target the microbiome to improve wound healing have already been demonstrated in the treatment
of atopic dermatitis (AD). AD skin lesions often have a reduced abundance of skin commensals
and, therefore, have resulted in a decreased production of AMPs [4,98,99]. One study found that
reintroduction of AMPs in human subjects resulted in a decreased colonization of AD lesions by
S. aureus [99]. Likewise, a multicenter study in AD patients in Germany found that treatment with a
lotion containing Lactobacillus johnsonii, a common probiotic strain, resulted in significantly increased
clinical improvement of AD lesions [98]. Gueniche et al. similarly found that topical application of
Vitreoscilla filiformis improved the healing of skin lesions in AD patients [100].
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S. aureus, Group A streptococcus which provides protection for pathogenic bacterium. Supplementation with
probiotics (e.g., Lactobacillus reuteri) accelerates wound healing although the mechanism is unknown.
CD8+ T Cells in response to S. epidermidis enhance rapid keratinocyte progression via Toll-like
receptor (TLR). Additionally, Pseudomonas accelerates epithelization and blood vessel growth through
transforming growth factor beta-activated kinase 1 (TAK1) signaling. Overabundance of S. aureus
produces superantigens (Sag) that are decreases interleukin (IL-17) and subsequently promoting
wound healing. Note the greater numbers of healthy fibroblast, macrophages, and neutrophils near
the wound bed and the intact vasculature that are essential in the healing process. Adjacent to the
wound is undamaged (healthy) skin that contains macrophages, fibroblast, and a healthy ecological
community of microorganisms that includes Gram Negatives, Gram Positives, fungi, and viruses
within the epidermis and hair shaft; (B) chronic wounds contain a biofilm and a dense population of
microorganisms which include anaerobic bacteria that obstruct wound healing by preventing topical
antibiotics reaching the wound bed. Quorum sensing within the biofilm promotes biofilm formation,
whereas exogenous topicals such as RNA inhibiting peptide inhibits biofilm formation. The biofilm
elevates the expression of cytokines IL-1B, IL-6, chemokine ligand (CXCL) 1 and 8. Bacterium in the
biofilm increase levels of IL-8 which is a potent neutrophil chemoattractant. Additionally, the biofilm
increases levels of TNF-α, and decreases IL-6, MMP-3, and vascular endothelial growth factor (VEGF).
Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) stimulates a host response
and is highly expressed in chronic wounds. The loss of vasculature to the wound bed further prevents
the migration of immune-related factors and delivery of exogenous therapeutics. Fibroblast migration
is impeded by biofilm formation Note the hyper-proliferative epidermis on the outer region of the
wound bed in an attempt to epithelialize the wound. Although inflammation is present in chronic
wounds the overall number of normal functioning fibroblasts and macrophages are low which further
prevents healing. Green font represents an exogenous treatment for wound healing.
Just as probiotics are widely commercially available for gastrointestinal issues, using probiotic
organisms to restore the skin microbiome and improve cutaneous healing also has promise.
Lactobacillus plantarum not only inhibits the production of elastase, biofilms, and acyl homoserine
lactone by Pseudomonas spp. in vitro, but also demonstrated inhibition of Pseudomonas colonization and
improved tissue repair in a burn mouse model [101]. In the presence of infection, L. plantarum containing
probiotics reduced collagen accumulation in Pseudomonas infected burn wounds, ultimately decreasing the
extent of scarring [102]. In chronic wounds, a randomized clinical trial revealed the potential advantageous
healing properties of probiotics in DFUs with significant reductions in ulcer length and depth, in addition
to improved glycemic control [103]. Similarly, Argenta et al. showed that L. plantarum showed an
80% decrease in mortality in a pseudomonas-infection porcine burn model [104]. Another possible
treatment for hard to heal wounds that deserves further exploration is Honeybee lactic acid bacteria;
when applied to chronic equine wounds this microbe promoted wound healing in all cases and
inhibited the growth of all pathogens in vivo [105]. In line with this, honey alone has been shown to
improve burn wound reepithelization rate despite a higher bacterial load when compared to 1% Silver
Sulphadiazine in a porcine model [106]. Finally, in a recent meta-analysis, Kasatpibal et al. showed that
symbiotic therapy reduces post-operative surgical site infection, pneumonia, sepsis, hospital stay and
duration of antibiotic administration [107]. Taken together, initial evidence suggests that probiotics
may be used in conjunction with antibiotics for the purposes of accelerated wound healing.
As mentioned earlier, short chain fatty acids (SCFAs) produced by skin commensals demonstrate
vital anti-microbial properties and incorporation of these metabolites into the treatment of cutaneous
wounds has high potential. When injected or applied topically, SCFAs such as acetic, butyric,
and propionic acid suppress cutaneous inflammation by promoting skin T-regulatory cells (Tregs) in
a histone acetylation dependent mechanism [108]. Furthermore, S. epidermidis increases the effect of
probiotics through production of poly-ethylene glycol dimethacrylate, an inductor of SCFAs, effectively
resulting in the decolonization of Methicillin Resistant Staphylococcus aureus (MRSA) strain in infected
skin wounds in rodents [109]. Poutahidis et al. revealed that supplementing the intestinal microbiome
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with the lactic acid bacteria Lactobacillus reuteri by adding it to drinking water, accelerated the cutaneous
wound healing process in animals two-fold due to up-regulation of the neuropeptide hormone
oxytocin [110]. This report showed that bacteria-induced oxytocin-activated FoxP3+CD25+host
immune Tregs, decreased the inflammatory damage caused by the innate immune system and led to
increased collagen deposition rates. Thus, both the cutaneous and gastrointestinal microbiome may
influence wound healing.
Disrupting the formation of biofilms represents another potential therapeutic target to improve
wound healing. As mentioned earlier, the application of quorum sensing inhibitors in a murine
wound model resulted in the obliteration of Staphylococcus produced biofilms and decreased bacterial
burden at the wound site [45]. Additional laboratory studies have supported the consensus that
the inhibition of microbial quorum sensing is successful at limiting biofilm formation [111–113].
Another potential approach is the introduction of engineered synthetic peptides that possess unique
anti-biofilm properties; these peptides are often derived from naturally produced host AMPs [114–116].
In a novel research study, Overhage et al. demonstrated that the naturally-produced human host
defense peptide 11–37 not only inhibited the formation of Pseudomonas produced biofilms in-vitro, but
also resulted in disruption of pre-grown bacterial biofilms [117]. This affect was achieved through
influencing quorum sensing, decreasing bacterial adherence, and downregulating genes required for
biofilm formation. Finally, a novel approach using predatory bacteria such as Bdellovibrio bacteriovirus
has been shown to reduce biofilm formation [118]. These bacteria effectively destroy a large number of
pathogens (especially Gram Negative species) and could have great implications for wound healing.
However, clinical studies using these approaches have not yet been conducted, and further research
in this field is needed in order to fully understand how the abrogation of biofilms may potentially
improve wound healing.
6. Conclusions
Culture-independent methodological tools have only just begun to identify the vast array of
microbial members that contribute to the cutaneous microbiome. In this review, we chose to focus
primarily on better known bacterial species since they currently have a greater influence on clinical
practice. However, with the advent of next-generation sequencing technology we are apt to discover
even more species that co-exist in and on our bodies. Yet, due to the limitations of cell culture,
the implications of these novel species are unclear. One of the major hurdles facing this field is
determining the effect of the microbiome on our health both at the level of the individual species and as
vast polymicrobial communities. Skin commensals such as Staphylococcus, Streptococcus, Pseudomonas,
Corynebacterium, and various anaerobes have both advantageous and detrimental effects, depending on
properties such as load and the hosts’ cutaneous environment. Skin commensals provide benign
tonic stimulation to the host’s immune system and deter invasion of other pathogenic microbes;
however, in the presence of tissue injury, loss of microbial diversity often results in prolonged
inflammation, which can delay wound healing. This intimate relationship with host inflammation
may reveal therapeutic targets that could circumvent or augment antibiotics, such as the introduction
of anti-microbial peptides through topical solutions. Furthermore, variables such as wound etiology,
location, and health status of the patient help dictate the dynamic constituents of skin commensals.
Recent research has allowed us to target the microbiome in various ways to improve wound healing;
restoration of the skin microbiome with Lactobacillus containing probiotics or applying agents that
disrupt biofilms may improve wound healing outcomes. Although substantial progress has been
made in microbiome research, further studies are needed in order to elucidate how the microbiome
impacts wound healing, and vice versa. In addition, while the mycobiome and virome influence
wound healing, they represent a potential untapped resource in the understanding and promoting of
wound healing. Ultimately, the goal is to leverage the knowledge gained on the skin microbiome to
promote the healing of both acute and chronic wounds.
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